Schedule 13G ownership disclosure

PERNIX THERAPEUTICS HOLDINGS, INC.

Security class unavailable · CUSIP: 71426V108

Event date: 2015-04-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,078,735
Percent of class
6.9400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-15-030541
Form type
SC 13G
Filer
Bracebridge Capital, LLC
CIK
CIK 1426486
Filed
Apr 27, 2015
Reporting period
Apr 16, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub